Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Calcium Level Controlling Activities of Novel Derivatives of Amlodipine,Riodipine and Cerebrocrast

Author(s): R. Vilskersts, B. Vigante, Z. Neidere, A. Krauze, I. Domracheva, L. Bekere, I. Shestakova, G. Duburs and M. Dambrova

Volume 9, Issue 3, 2012

Page: [322 - 328] Pages: 7

DOI: 10.2174/157018012799129909

Price: $65

Abstract

A novel series of asymmetric 4-aryl-1,4-dihydropyridine (1,4-DHP) 3,5-diester derivatives and their symmetric analogues comprised of functional moieties of amlodipine, riodipine and cerebrocrast have been synthesized. The calcium channel blocking activity was evaluated in an isolated rat aortic ring model. The calcium overload preventing activity was tested in SH-SY5Y neuroblastoma cell line by a fluorescence-based calcium assay. Among synthesized and tested compounds, 4a showed the highest calcium overload preventing activity (IC50=39μM) and 7e demonstrated the highest calcium channel inhibiting activity (EC50=0.2 nM). Asymmetric ester 7a exerted both substantial calcium channel blocking and calcium overload preventing activity.

Keywords: Amlodipine, Asymmetric 1,4-dihydropyridines, Calcium channel antagonists, Cerebrocrast, Riodipine, 1,4-DHP, Calcium Level, Cardiovascular diseases, Varian Mercury, apoptosis, neuroprotective propertie, antihypertensive agents, NMR spectra, Aortic Ring Experiment


© 2024 Bentham Science Publishers | Privacy Policy